
InterSol Solution/Platelet Additive Solution 3
Product name: InterSol Solution/ Platelet Additive Solution 3
Manufacturer: Fenwal, Inc,
Intended Use: InterSol solution is an isotonic solution designed to replace a proportion of the plasma used in the storage of AMICUS™-derived leukoreduced apheresis platelets under standard blood banking conditions.
Approval Date: December 9, 2009
Type of submission: New Drug Application
NDA Number: BN080041/0
Production Information
Package Insert - InterSol (PDF - 160KB)
pdf, abrir aquí: http://www.fda.gov/downloads/BiologicsBloodVaccines/BloodBloodProducts/ApprovedProducts/NewDrugApplicationsNDAs/UCM193796.pdf
abrir aquí:
InterSol Solution/Platelet Additive Solution 3


No hay comentarios:
Publicar un comentario